acetylgalactosamine has been researched along with Allergic Encephalomyelitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alpar, AT; Antane, JT; Bischoff, DJ; Budina, E; Conley, GP; Dereuddre-Bosquet, N; Gallouët, AS; Harrington, JL; Hubbell, JA; Kontos, S; LeGrand, R; Lorentz, KM; Marlin, R; Maulloo, CD; Mishra, R; Nguyen, M; Raczy, MR; Reda, JW; Slezak, AJ; Solanki, A; Thornley, TB; Tremain, AC; Wallace, RP; Watkins, EA; Wilson, DS | 1 |
Arikawa, T; Hirashima, M; Kadowaki, T; Niki, T; Nishi, N; Oomizu, S; Ueno, M; Yamauchi, A | 1 |
2 other study(ies) available for acetylgalactosamine and Allergic Encephalomyelitis
Article | Year |
---|---|
Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Topics: Acetylgalactosamine; Animals; Autoimmunity; Encephalomyelitis, Autoimmune, Experimental; Glycosylation; Immune Tolerance; Mice | 2023 |
Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.
Topics: Acetylgalactosamine; Animals; Benzyl Compounds; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Forkhead Transcription Factors; Galectins; Hepatitis A Virus Cellular Receptor 2; Interleukin-17; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Virus; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta1 | 2012 |